Department of Molecular Nutrition, CSIR-Central Food Technological Research Institute, Mysuru, 570020, Karnataka, India.
Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
Eur J Nutr. 2023 Sep;62(6):2489-2507. doi: 10.1007/s00394-023-03162-4. Epub 2023 May 8.
Obesity is a growing global health concern. Recent literature indicates a prominent role of glucagon-like peptide-1 (GLP-1) in glucose metabolism and food intake. The synergistic action of GLP-1 in the gut and brain is responsible for its satiety-inducing effect, suggesting that upregulation of active GLP-1 levels could be an alternative strategy to combat obesity. Dipeptidyl peptidase-4 (DPP-4) is an exopeptidase known to inactivate GLP-1, suggesting that its inhibition could be a crucial strategy for effectively extending the half-life of endogenous GLP-1. Peptides derived from partial hydrolysis of dietary proteins are gaining traction due to their inhibitory activity on DPP-4.
Whey protein hydrolysate from bovine milk (bmWPH) was produced using simulated in situ digestion, purified using RP-HPLC, and characterized for DPP-4 inhibition. The antiadipogenic and antiobesity activity of bmWPH was then studied in 3T3-L1 preadipocytes and high-fat diet-induced obesity (HFD) mice model, respectively.
The dose-dependent inhibitory effect of bmWPH on the catalytic activity of DPP-4 was observed. Additionally, bmWPH suppressed adipogenic transcription factors and DPP-4 protein levels, leading to a negative effect on preadipocyte differentiation. In an HFD mice model, co-administration of WPH for 20 weeks downregulated adipogenic transcription factors, resulting in a concomitant reduction in whole body weight and adipose tissues. Mice fed with bmWPH also showed a marked reduction in DPP-4 levels in WAT, liver, and serum. Furthermore, HFD mice fed with bmWPH exhibited increased serum and brain GLP levels, which led to a significant decrease in food intake.
In conclusion, bmWPH reduces body weight in HFD mice by suppressing appetite through GLP-1, a satiety-inducing hormone, in both the brain and peripheral circulation. This effect is achieved through modulation of both the catalytic and non-catalytic activity of DPP-4.
肥胖是一个日益严重的全球健康问题。最近的文献表明,胰高血糖素样肽-1(GLP-1)在葡萄糖代谢和食物摄入中起着重要作用。GLP-1 在肠道和大脑中的协同作用是其产生饱腹感的原因,这表明上调活性 GLP-1 水平可能是对抗肥胖的一种替代策略。二肽基肽酶-4(DPP-4)是一种已知能使 GLP-1 失活的外肽酶,这表明抑制 DPP-4 可能是有效延长内源性 GLP-1 半衰期的关键策略。来源于膳食蛋白质部分水解的肽由于其对 DPP-4 的抑制活性而受到关注。
使用模拟原位消化生产来自牛乳的乳清蛋白水解物(bmWPH),使用反相高效液相色谱法(RP-HPLC)纯化,并对其 DPP-4 抑制作用进行了表征。然后,在 3T3-L1 前体脂肪细胞和高脂肪饮食诱导肥胖(HFD)小鼠模型中分别研究了 bmWPH 的抗脂肪生成和抗肥胖活性。
观察到 bmWPH 对 DPP-4 催化活性的剂量依赖性抑制作用。此外,bmWPH 抑制了脂肪生成转录因子和 DPP-4 蛋白水平,对前体脂肪细胞分化产生了负面影响。在 HFD 小鼠模型中,20 周共给予 WPH 可下调脂肪生成转录因子,导致全身重量和脂肪组织的同时减少。用 bmWPH 喂养的小鼠还显示出 WAT、肝脏和血清中 DPP-4 水平的显著降低。此外,用 bmWPH 喂养的 HFD 小鼠表现出血清和脑中 GLP 水平的显著增加,这导致食物摄入量的显著减少。
总之,bmWPH 通过在大脑和外周循环中通过 GLP-1 抑制食欲来降低 HFD 小鼠的体重,GLP-1 是一种饱腹感激素。这种作用是通过调节 DPP-4 的催化和非催化活性来实现的。